To investigate the efficacy and safety of endoscopic ultrasound (EUS)-guided coil combined with tissue glue embolization for visceral arterial pseudoaneurysms (VAPA), clinical data of 4 patients who underwent this procedure at the Endoscopy Center of Qilu Hospital, Shandong University between June 2024 and March 2025 were retrospectively analyzed. Parameters including technical success rate, procedure time, postoperative complications, costs, and postoperative hospital stay were recorded. The technical success rate was 100%, with embolization time ranging from 100 seconds to 260 seconds. No severe complication occurred in any patient. The procedure costs varied between 7.6 thousand yuan and 13.6 thousand yuan, with postoperative hospitalization lasting 2-3 days. During the follow-up period of 2.0-11.0 months, no VAPA recurrence was observed in any case. This preliminary study demonstrates that EUS-guided coil combined with tissue glue may represent a feasible and safe novel therapeutic approach for VAPA. It is worth clinical application for no radiation, minimal invasiveness, short procedure time and cost-effectiveness .

To investigate the efficacy and safety of endoscopic ultrasound (EUS)-guided coil combined with tissue glue embolization for visceral arterial pseudoaneurysms (VAPA), clinical data of 4 patients who underwent this procedure at the Endoscopy Center of Qilu Hospital, Shandong University between June 2024 and March 2025 were retrospectively analyzed. Parameters including technical success rate, procedure time, postoperative complications, costs, and postoperative hospital stay were recorded. The technical success rate was 100%, with embolization time ranging from 100 seconds to 260 seconds. No severe complication occurred in any patient. The procedure costs varied between 7.6 thousand yuan and 13.6 thousand yuan, with postoperative hospitalization lasting 2-3 days. During the follow-up period of 2.0-11.0 months, no VAPA recurrence was observed in any case. This preliminary study demonstrates that EUS-guided coil combined with tissue glue may represent a feasible and safe novel therapeutic approach for VAPA. It is worth clinical application for no radiation, minimal invasiveness, short procedure time and cost-effectiveness .

Transient receptor potential vanilloid-1(TRPV1) channel is a non-selective ligand-gated cationic channel with multiple activation mechanisms in the transient receptor potential subfamily. In recent years, a large number of studies have found that TRPV1 plays an important role in the field of cardiovascular diseases such as hypertension and atherosclerosis. With the in-depth study of traditional Chinese medicine, it has been found that Chinese medicine monomers and their active components can activate or inhibit TRPV1 channels, which has certain potential in the study of cardiovascular diseases. In this paper, the role of TRPV1 channel in cardiovascular diseases and the research progress of traditional Chinese medicine prevention and treatment of cardiovascular diseases based on TRPV1 channel are reviewed, in order to provide new ideas for prevention and treatment of cardiovascular system diseases.